495 related articles for article (PubMed ID: 2215269)
41. Contraception for the perimenopausal patient.
Upton GV
Obstet Gynecol Clin North Am; 1987 Mar; 14(1):207-27. PubMed ID: 3306520
[TBL] [Abstract][Full Text] [Related]
42. Oral contraceptive and postmenopausal estrogen effects on lipoprotein triglyceride and cholesterol in an adult female population: relationships to estrogen and progestin potency.
Knopp RH; Walden CE; Wahl PW; Hoover JJ; Warnick GR; Albers JJ; Ogilvie JT; Hazzard WR
J Clin Endocrinol Metab; 1981 Dec; 53(6):1123-32. PubMed ID: 7298796
[TBL] [Abstract][Full Text] [Related]
43. Endometrial histology and biochemistry in climacteric women during oestrogen and oestrogen/progestogen therapy.
Whitehead MI; King RJ; McQueen J; Campbell S
J R Soc Med; 1979 May; 72(5):322-7. PubMed ID: 552525
[TBL] [Abstract][Full Text] [Related]
44. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
Goldzieher JW; de la Peña A; Chenault CB; Cervantes A
Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928
[TBL] [Abstract][Full Text] [Related]
45. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
Genazzani AR; Gadducci A; Gambacciani M
Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
[TBL] [Abstract][Full Text] [Related]
46. Oral contraception reviewed.
Elstein M
IPPF Med Bull; 1979 Jun; 13(3):1-2. PubMed ID: 12335871
[TBL] [Abstract][Full Text] [Related]
47. Effect of the combined steroidal contraceptives (Gynanovlar 21 and Lyndiol 2.5) on the human adrenocortical and ovarian activities.
Zaki K; Kamal I; Talaat MM; Rashad S; Nour H
Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):41-65. PubMed ID: 12256027
[TBL] [Abstract][Full Text] [Related]
48. Pharmacodynamic effects of once-a-month combined injectable contraceptives.
Sang GW
Contraception; 1994 Apr; 49(4):361-85. PubMed ID: 8013220
[TBL] [Abstract][Full Text] [Related]
49. The effects of progesterone and progestins on endometrial proliferation.
Moyer DL; Felix JC
Contraception; 1998 Jun; 57(6):399-403. PubMed ID: 9693400
[TBL] [Abstract][Full Text] [Related]
50. The risks of oral contraceptives and estrogen replacement therapy.
Coe FL; Parks JH
Perspect Biol Med; 1989; 33(1):86-106. PubMed ID: 2689999
[TBL] [Abstract][Full Text] [Related]
51. Plasma lipoprotein changes during oral contraception.
Briggs MH; Briggs M
Curr Med Res Opin; 1979; 6(4):249-54. PubMed ID: 527349
[TBL] [Abstract][Full Text] [Related]
52. Effectiveness of Cyclofem in the treatment of depot medroxyprogesterone acetate induced amenorrhea.
Piya-Anant M; Koetsawang S; Patrasupapong N; Dinchuen P; d'Arcangues C; Piaggio G; Pinol A
Contraception; 1998 Jan; 57(1):23-8. PubMed ID: 9554247
[TBL] [Abstract][Full Text] [Related]
53. The evolving role of oral hormonal therapies and review of conjugated estrogens/bazedoxifene for the management of menopausal symptoms.
Parish SJ; Gillespie JA
Postgrad Med; 2017 Apr; 129(3):340-351. PubMed ID: 28132583
[TBL] [Abstract][Full Text] [Related]
54. Serum lipids and lipoproteins during treatment with oral contraceptives containing natural and synthetic oestrogens. A controlled double-blind investigation.
Bostofte E; Hemmingsen L; Møller KJ; Serup J; Weber T
Acta Endocrinol (Copenh); 1978 Apr; 87(4):855-64. PubMed ID: 347855
[TBL] [Abstract][Full Text] [Related]
55. [Hormones and lupus].
Gompel A; Pelissier C; Kuttenn F; Mauvais-Jarvis P
Rev Med Interne; 1985 Dec; 6(5):543-52. PubMed ID: 3914021
[TBL] [Abstract][Full Text] [Related]
56. Oestriol deficiency, a possible factor in the aetiology of thrombo-embolism in pill users.
Zaki K; Sami G; Nour H
Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):19-24. PubMed ID: 12256026
[TBL] [Abstract][Full Text] [Related]
57. Carbohydrate metabolism during treatment with estrogen, progestogen, and low-dose oral contraceptives.
Spellacy WN
Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):732-4. PubMed ID: 7039318
[TBL] [Abstract][Full Text] [Related]
58. The morphologic response of the human endometrium to long-term treatment with progestational agents.
Ludwig H
Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):796-808. PubMed ID: 7065058
[TBL] [Abstract][Full Text] [Related]
59. Progestogens in cardiovascular diseases: an introduction to the epidemiologic data.
Mann JI
Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):752-7. PubMed ID: 7065056
[TBL] [Abstract][Full Text] [Related]
60. Contraception with progestogens and progesterone during lactation.
Shaaban MM
J Steroid Biochem Mol Biol; 1991; 40(4-6):705-10. PubMed ID: 1835650
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
